Cancer Biotherapy and Radiopharmaceuticals
| Cancer Biotherapy and Radiopharmaceuticals
|
|
|---|---|
| description | Peer-reviewed journal |
| Area of Expertise | Medicine , pharmacy and pharmacology |
| language | English |
| publishing company | Mary Ann Liebert ( United States of America ) |
| First edition | 1983 |
| Frequency of publication | 10 issues a year |
| Web link | Website of the journal |
| ISSN (print) | 1084-9785 |
Cancer Biotherapy and Radiopharmaceuticals , abbreviated to Cancer Biother. Radiopharm. , is a scientific journal published by Mary Ann Liebert-Verlag.
description
The journal was founded in 1983 under the name Cancer Drug Delivery , in 1989 the name was changed to Selective Cancer Therapeutics . In 1993 the name was changed to Cancer Biotherapy and in 1996 extended to Cancer Biotherapy and Radiopharmaceuticals . The magazine is published ten times a year. Works are published that deal with the use of biologicals and radioimmunotherapeutic agents for tumor therapy.
The impact factor in 2014 was 1.778. According to the statistics of the ISI Web of Knowledge , the journal with this impact factor ranks 163rd out of 254 journals in the pharmacology and pharmacy category , 80th out of 123 journals in the experimental and research-based medicine category , and 165th in the oncology category 1st place out of 211 journals and 60th place out of 125 journals in the radiology, nuclear medicine and medical imaging category.
Individual evidence
- ^ Website of the journal ; accessed on May 2, 2015.
- ↑ 2014 Journal Citation Reports, Science Edition (Thomson Reuters, 2015).